U.S. Senate drops proposed pay-for-delay ban; Pfizer sells New London complex for $55M;

 @FiercePharma: Report: Sanofi approaches Genzyme with buyout deal. Article | Follow @FiercePharma

> The U.S. Senate dropped a House provision that would have restricted brand-name drug companies from paying generic-drug makers to delay putting lower-priced pharmaceuticals on the market. Report

> New documents show submarine maker Electric Boat is buying Pfizer's former global research and development complex in Connecticut for $55 million. News

> More than 600 workers at AstraZeneca's Macclesfield, England, drug factory are holding a strike ballot over changes to their pension scheme. Article

> Spanish pharmaceutical company Almirall reached an agreement with Pfizer to distribute the U.S. company's new osteoporosis drug, Conbriza, in Spain. Story

> The FDA has asked Ampac Fine Chemicals for a more detailed plan to fix manufacturing deviations at its API plant in Rancho Cordova, California. Report

> Israel's Comptroller has launched an investigation into the financial ties between drugmakers and various health-care organizations. Item

> Daiichi Sankyo will form a joint venture with Kitasato Institute Research Center for Biologicals to make vaccines as early as next spring, Nikkei English News said. Report

> GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis. Story

> Glenmark Pharmaceuticals said a unit has received tentative FDA approval to sell a generic version of Medicis Pharmaceutical's Vanos cream for treating skin problems. News

Biotech News

 @FierceBiotech: GlobeImmune cuts 25 percent of staff. Article | Follow @FierceBiotech

> Is a bidding war for Genzyme looming? Article

> Cerenis lands $65M for mid-stage cholesterol drug program. Item

> Sandoz chief predicts big wave of biosimilars. Report

> Immune Design nabs $32M for vaccine development. Article

> Onyx will seek early approval on blockbuster cancer candidate. Story

Biotech IT News

> E-clinical solution adds mobility, language support. Article

> Cancer trials halted amid investigations. News

> Halt to Pfizer, GSK trials tests e-clinical data savvy. Report

> Service locates lost trial subjects, data. Story

And Finally... Pfizer has put two widely used mental health assessment tools online for the public to use. Report